Macroencapsulation of cells allows to isolate the donor biomaterial from the influence of the recipient’s organism. The degree of isolation can vary from mechanical isolation of donor cells within the implantation site to complete immune isolation of the transplanted biological material. The diffusion chamber was the first device used for macroencapsulation. The initial stage of research of this technique was aimed at expanding the range of cell and tissue implantation in allogenic and xenogenic models and clarifying the mechanisms underlying the graft rejection reaction. Later the design of the diffusion chamber underwent a number of changes that determined the modern application of the macroencapsulation method. The derivative of the diffusion chamber – the engineering chamber in complex with the arterio-venous shunt is used as a tissue modeling tool for creation of soft tissue flaps of different composition with the axial type of blood supply. An alternative design of the flow chamber allows the formation of soft tissue flaps on intact vessels. The engineering chamber is also used for growing various types of tissues and organ fragments (cardiac transverse striated muscle tissue, lymphoid tissue, fragments of liver, thymus, pancreas). A separate direction in studying the range of practical applications of the diffusion chamber is the development and testing of methods of transplantation of pancreatic islet cells into animals when creating allo- and xenogeneic experimental models for the treatment of diabetes mellitus. Some devices are already undergoing clinical trials and are available as a product for experimental studies.
Read full abstract